Sources | Names Used |
---|---|
CTRPv2 | BRD-K16147474 |
PharmacoGx | BRD-K16147474 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TLL1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
mRNA | RHO | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
mRNA | PHF20 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
mRNA | EXTL2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
mRNA | EGR4 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
mRNA | FSCN2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
mRNA | RETNLB | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
mRNA | LRCH4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
mRNA | MORF4L1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
mRNA | C8orf33 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |